Clinical Neurological Society of America

#DYK? Patients with #PseudobulbarAffect show frequent uncontrollable outbursts of laughing or crying that don’t reflect their internal emotional state. Read more in CNSA's white paper: bit.ly/3WMwz5Y

Episode 6 of CNSA's 6-part series highlights Sharon Cohen, MD, FRCPC, as she speaks about what's in the treatment pipeline for #AlzheimersDisease. Watch to learn more: bit.ly/4kWO5Bb Read paper: bit.ly/3YSNTs9

#RhettSyndrome is estimated to affect one in 10,000 females globally, but because cases can go undiagnosed or be misdiagnosed, it is difficult to determine its actual frequency in the population. Read more: bit.ly/3pWaUwJ

Episode 5 of CNSA's 6-part series highlights Suzanne E. Schindler, MD, PhD (@SuzanneESchind1), who discusses the realities of treating #AlzheimersDisease through the perspective of a clinician. Watch to learn more: bit.ly/3TYEddH Read paper: bit.ly/3YSNTs9

Earlier today, CNSA joined @ResearchAmerica on Capitol Hill to discuss the urgent need for innovative partnerships & policies to tackle #Alzheimers. CNSA remains committed to accelerating the breakthroughs necessary to improve the lives of those living with Alzheimer's disease.

The CIDP Ambassador Program, a collaboration between CNSA and Grifols, is an educational program on improving the recognition, diagnosis and treatment of #CIDP. Learn more: bit.ly/4eCLsR3

This week is #BrainAwarenessWeek! #BAW is an opportunity to let people know about the progress that is being done in brain research as well as progress in the diagnosis, treatment and prevention of disorders of the brain. Learn more: bit.ly/3a2xoEh

#CAE is one of the most common pediatric epilepsy syndromes, affecting 10% to 18% of all children with epilepsy in the United States. Hear from experts as they discuss how #CAE is underrecognized yet easily diagnosed and treated. Watch to learn more: bit.ly/3UM8eNt

DYK? Acute attacks in #AIP are often precipitated by internal or external factors such as: 🔹 Hormones 🔹 Stress 🔹 Alcohol 🔹 Smoking Read more: bit.ly/4qIiG7S

Episode 4 of CNSA's 6-part series highlights Irina Anna Skylar-Scott, MD, who talks about anti-amyloid treatments for #AlzheimersDisease. Watch to learn more: bit.ly/3I1vJzw Read paper: bit.ly/3YSNTs9

Interested in becoming a member of CNSA? CNSA's mission is to improve clinical practice and patient care through education and thought leadership. Join or renew here: bit.ly/3okHSCl

To improve care for those with #epilepsy, particularly those with difficult-to-diagnose and drug-resistant epilepsy, patients need more access to specialized care, including #EMUs. Read more: bit.ly/4c3VeNP

#ICYMI: CNSA hosted a webinar highlighting #epilepsy and the importance of #EpilepsyMonitoringUnits. Watch the recording now: bit.ly/4qYxqPa

Expanding awareness of #CAE, its symptoms and impact on learning and mental health among patients may help with early recognition and treatment of the disease. Read more about childhood absence epilepsy in CNSA's paper: bit.ly/4bvco3l

CNSA has a 6-part video series about "Alzheimer's Disease: From Pre-diagnosis to Treatment to What's Next." Watch the video series to learn more: bit.ly/4jwuab1 @SuzanneESchind1

TODAY at 11 am ET, CNSA is hosting its webinar, "The Impact & Unmet Needs of Epilepsy & the Value of Epilepsy Monitoring Units." If you haven't already, register to hear experts discussing CNSA's newest Clinical Proceedings white paper and more: bit.ly/3OhifCS

This Clinical Proceedings webinar explores the perspectives of clinical neurologists and allied health care professionals on the burden and impact of acute intermittent porphyria, as well as the diagnosis and management of people with #AIP. Watch now: bit.ly/4p9DSTo

#AlzheimersDisease is distinguished from other forms of dementia by deposition and accumulation of two proteins in certain areas of the brain: 🟢 Amyloid-beta 🟢 Tau Learn more in CNSA's paper about Alzheimer's and the trend toward biological diagnosis: bit.ly/3YSNTs9

NEXT WEEK, join CNSA's webinar, "The Impact & Unmet Needs of Epilepsy & the Value of Epilepsy Monitoring Units." Speakers include: 🟢 Daniel Friedman, MD 🟢 Gregory Bergey, MD 🟢 Tanya Kehoe, PA-C 🟢 Mohamad Koubeissi, MD 🟢 John Stern, MD Register NOW: bit.ly/3OhifCS

#DYK? #ParkinsonsDisease is the second most common neurodegenerative disorder, behind Alzheimer’s disease, affecting around 1 million people in the United States. Read more: bit.ly/4jrpfbh